January 19, 2021: The World Trade Organisation TRIPS Council is today debating again the proposal by India and South Africa, supported by 100 countries, to waive various intellectual property provisions on COVID technology. Big Pharma has defended its 20-year monopoly on new medicines and the MSF medicine access movement has rebutted their claims.
January 13, 2021: Medicines experts Professors Ronald Labonte and Brook Baker explain in The Conversation why 100 developing country members of the World Trade Organisation’s 164 members are demanding a temporary waiver of some intellectual property rights, supported by hundreds of public health and other community organisations.
December 15, 2020: The Report of the Joint Standing Committee on Foreign Affairs Defence and Trade on the implications of the COVID-19 pandemic for Australia’s foreign affairs defence and trade policies was tabled in Parliament on December 8.
December 14, 2020: The World Trade Organization TRIPS Council failed to act on December 10, 2020, on the proposal by South Africa and India to temporarily waive some intellectual property rights, so that Covid-19 medical products and vaccines could be more easily accessible, especially for low-income countries.
December 7, 2020: An Open Letter from the World Federation of Public Health Associations to the World Trade Organisation, the World Health Organisation, the World Intellectual Property Organisation and to the UN Secretary-General is aimed at a breakthrough on access to vaccines at the December 9 session of the TRIPS Council of the WTO.
December 1, 2020: Any COVID-19 vaccines need to be freely accessible to all countries, but this requires a waiver to some World Trade Organisation rules, argues Rachel Thrasher, a Research Fellow at Boston’s Global Development Policy Center.
November 23, 2020: The United States, the European Union and other mainly wealthy nations gathered in Geneva on November 21, 2020, to reiterate their opposition to a proposal to waive intellectual property rules for COVID-19 drugs, according to a Reuters report, despite pressure to make an exception to improve access to these drugs for poorer countries.
Media release November 14, 2020: “The giant RCEP trade deal will be signed tomorrow by Australia, New Zealand, China, Japan, South Korea and the 10 ASEAN countries (but without India) with great fanfare about its claimed economic benefits. But the deal was completed before the COVID-19 pandemic, and has not been revised in the light of lessons from the pandemic. Like previous trade deals the RCEP restricts local industry policies,” AFTINET Convener Dr Patricia Ranald said today.
November 11, 2020: UN Human Rights Experts on November 9 called on the 31st Special Session of the General Assembly in Response to the COVID-19 Pandemic to base their response on the bedrock human-rights based principles of international solidarity, cooperation and assistance.
November 9, 2010: The Australian government recently announced new spending of A$500 million over three years to ensure provide COVID-19 vaccines and immunisation technical support to Papua New Guinea, Solomon Islands, Vanuatu, Fiji, Samoa, Tonga, Tuvalu and Kiribati in the Pacific, and Indonesia, Timor-Leste, Cambodia, Laos, Myanmar, the Philippines and Vietnam in south-east Asia.